Improving Outcomes in Patients with CRC: The Role of Patient Reported Outcomes—An ESDO Report
AbstractColorectal cancer is one of the most commonly diagnosed cancers worldwide and nearly half of patients will develop metastatic disease at some point during the course of their disease. The goal of anticancer therapy in this context is to extend survival, while trying to maximise the patient’s health-related quality of life. To this end, we need to understand how to incorporate patient-reported outcomes into clinical trials and routine practice to accurately assess if treatment strategies are providing clinical benefit for the patient. This review reflects the proceedings of a 2016 European Society of Digestive Oncology workshop, where the authors discussed the use of patient-reported outcomes to measure health-related quality of life when evaluating treatment during the management of colorectal cancer. A summary of the challenges associated with implementing patient-reported outcomes in clinical trials is provided, as well as a review of the current clinical evidence surrounding patient-reported outcomes in metastatic colorectal cancer. View Full-Text
Share & Cite This Article
Van Cutsem, E.; De Gramont, A.; Henning, G.; Rougier, P.; Bonnetain, F.; Seufferlein, T. Improving Outcomes in Patients with CRC: The Role of Patient Reported Outcomes—An ESDO Report. Cancers 2017, 9, 59.
Van Cutsem E, De Gramont A, Henning G, Rougier P, Bonnetain F, Seufferlein T. Improving Outcomes in Patients with CRC: The Role of Patient Reported Outcomes—An ESDO Report. Cancers. 2017; 9(6):59.Chicago/Turabian Style
Van Cutsem, Eric; De Gramont, Aimery; Henning, Geoffrey; Rougier, Philippe; Bonnetain, Franck; Seufferlein, Thomas. 2017. "Improving Outcomes in Patients with CRC: The Role of Patient Reported Outcomes—An ESDO Report." Cancers 9, no. 6: 59.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.